Kura Oncology (KURA) Amortization of Deferred Charges (2016 - 2026)
Kura Oncology (KURA) reported Amortization of Deferred Charges of $106000.0 for Q1 2026, down 20.3% year-over-year from $133000.0 in Q1 2025, and up 2.91% quarter-over-quarter from $103000.0 in Q4 2025.
Kura Oncology (KURA) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Kura Oncology (KURA) has 7 years of Amortization of Deferred Charges data on file, last reported at $106000.0 in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $106000.0, down 20.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $488000.0 (down 8.61% YoY), and the FY2025 annual result was $515000.0, down 1.53% from the prior year.
- Amortization of Deferred Charges grew to $106000.0 in Q1 2026 per KURA's latest filing, from $103000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $141000.0 in Q3 2025 and troughed at $103000.0 in Q4 2025.
- A 4-year average of $124692.3 and a median of $122000.0 in 2023 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2024 and 2025: Amortization of Deferred Charges climbed 17.65% in 2024, then slipped 26.43% in 2025.
- A 4-year view of Amortization of Deferred Charges shows it stood at $119000.0 in 2023, then grew by 17.65% to $140000.0 in 2024, then retreated by 26.43% to $103000.0 in 2025, then climbed by 2.91% to $106000.0 in 2026.
- Business Quant data shows KURA's Amortization of Deferred Charges at $106000.0 in Q1 2026, $103000.0 in Q4 2025, and $141000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | 141,000.00 |
| Sep 30, 2025 | 141,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 133,000.00 |
| Mar 31, 2025 | 133,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 119,000.00 |
| Dec 31, 2023 | 119,000.00 |